Skip to main content
Caplight Logo









ECM Therapeutics, Inc.

ECM Therapeutics, Inc.

Private
PennsylvaniaHealthcare & Life Scienceshttps://ecmtherapeutics.com/

Last Round

VC Round

May 28, 2018

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ECM Therapeutics, Inc. is a biotechnology company that develops and manufactures therapeutic products derived from extracellular matrix (ECM) for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicineextracellular matrixECMinjectable hydrogeltissue restorationanorectal fistula treatmentbiomaterialstissue engineeringnon-surgical therapycell-free therapyclinical-stage biotechbiologics manufacturingmatrix-bound nanovesiclesMBV platformadvanced wound careocular repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ECM Therapeutics, Inc. Comparables

Compare ECM Therapeutics, Inc. with similar companies based on industry and business-model similarity.

ECM Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RegenX Science
83%
XM Therapeutics
74%
Cook Group Incorporated
74%

ECM Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 28, 2018

Key People

Founding team and executive leadership

Paul Fagan

Chief Executive Officer

Executive Team

ECM Therapeutics, Inc. Investors

Notable investors and investment history

ECM Therapeutics, Inc. investors
InvestorRounds
University of Pittsburgh Investment OfficeVC Round
Kineticos VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 39% MoM, reaching 2.4K.

  • May 28, 2018

    $35.2M round with participation from Kineticos Ventures.

ECM Therapeutics, Inc. Filings

Explore SEC and related filing metadata, where available.

ECM Therapeutics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ECM Therapeutics, Inc.'s valuation, stock price, and market status.

Is ECM Therapeutics, Inc. a public or private company?

ECM Therapeutics, Inc. is a private company.

What is the current stock price of ECM Therapeutics, Inc.?

ECM Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is ECM Therapeutics, Inc. worth (valuation)?

Valuation information for ECM Therapeutics, Inc. is not publicly available.

Can I buy ECM Therapeutics, Inc. stock?

ECM Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ECM Therapeutics, Inc.'s last funding round?

ECM Therapeutics, Inc.'s most recent funding round was VC Round on May 28, 2018.

Who are the main investors in ECM Therapeutics, Inc.?

Key investors in ECM Therapeutics, Inc. include University of Pittsburgh, Kineticos Ventures.

Will ECM Therapeutics, Inc. IPO soon?

No public IPO plans have been announced for ECM Therapeutics, Inc..

How can I track ECM Therapeutics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ECM Therapeutics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPennsylvania
Employee Range10
Year Founded2018
Last FundingMay 28, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?